About Titan Biotech Limited
Data last updated: 24 December 2025
Titan Biotech Limited is a public limited company based in Bhiwadi, Rajasthan, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 18 February 1992, the company has been in operation for over 34 years.
Registered with ROC Jaipur under CIN L74999RJ1992PLC013387. Listed on BSE: 524717.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.26 Cr. Formerly known as Titan Medicares Limited and Titan Biotech Limited. It is led by directors including Debendra Kumar Sabat and Suresh Chand Singla.
Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 902 A Riico.Indl.Area Phase – Iii, Bhiwadi, Rajasthan, India – 301019.
As per the financials filed for FY 2025, the company reported a revenue of ₹160.36 Cr, a decline of 3% compared to the previous year.
The company has a workforce of approximately 377 employees as per the latest available data.
The company is associated with 1 brand - Titan Biotech. As per MCA filings, the company has open charges of ₹21.19 Cr and satisfied charges of ₹37.52 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website titanbiotechltd.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressA – 902 A Riico.Indl.Area Phase – Iii, Bhiwadi, Rajasthan, India – 301019
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Titan Biotech Limited
Titan Biotech Limited has undergone 2 name changes throughout its history. The company was previously known as Titan Medicares Limited, and Titan Biotech Limited. The current legal name is Titan Biotech Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Titan Biotech Limited | Current |
| Titan Medicares Limited | Previous |
CIN History of Titan Biotech Limited
Titan Biotech Limited has one previous CIN (Corporate Identification Number): L74999RJ1997PLC013387. The current CIN is L74999RJ1992PLC013387, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74999RJ1992PLC013387 | Current |
| L74999RJ1997PLC013387 | Previous |
Associated Brands with Titan Biotech Limited
Titan Biotech Limited operates one associated brand: Titan Biotech. These brands represent Titan Biotech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Biological products are manufactured and exported for various industries. | titanbiotechltd.com |
Competitors & Alternatives of Titan Biotech Limited
Brands and companies operating in the same space as Titan Biotech Limited include IPL Biologicals, Univia, Sri Biotech Laboratories and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
IPL Biologicals
|
Plant nutrition and protection products are manufactured and supplied. | Gurugram, India, India | 1994 |
Univia
|
Agri-input retailers are connected to farmers via a phygital network. | Ahmedabad, India, India | 2020 |
Sri Biotech Laboratories
|
Crop improvement research and nutrient manufacturing are conducted. | Hyderabad, India, India | 1994 |
Capsber
|
Diversified crop biological solutions are provided for farmers. | Bengaluru, India, India | 2022 |
Absolute
|
Biological technologies are developed for agriculture, healthcare, and materials science. | Gurugram, India, India | 2015 |
Lab2Land
|
Agrochemicals, fertilizers, and crop nutrition solutions are researched and developed. | Hyderabad, India, India | 2020 |
Criyagen
|
Develops innovative technologies for organic and bio-active farm inputs. | Bengaluru, India, India | 2008 |
Shivashakthi BioTechnologies
|
Development and commercial production of plantlets and farm inputs | Hyderabad, India, India | 2001 |
Varsha Bioscience and Technology
|
Bio-pesticides, bio-fertilizers, and plant growth promoters are manufactured. | Hyderabad, India, India | 2003 |
Business Activity of Titan Biotech Limited
Titan Biotech Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Titan Biotech Limited
Titan Biotech Limited is audited by A N S K & Associates (ICAI peer reviewed, certificate valid till 2028-04-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| A N S K & Associates (ICAI peer reviewed, certificate valid till 2028-04-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Titan Biotech Limited
Titan Biotech Limited is currently managed by 15 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Debendra Kumar Sabat
Also directs:
Titan Biotech Limited
|
Director | 13 Aug 2025 | 0 Years 10 Months | Current |
|
Suresh Chand Singla
Also directs:
Titan Securities Limited, Titan Biotech Limited, Simtex Mart Private Limited and 5 more
|
Managing Director | 01 Oct 2012 | 13 Years 9 Months | Current |
|
Manju Singla
Also directs:
Titan Securities Limited, Titan Biotech Limited, Simtex Mart Private Limited and 2 more
|
Director | 23 Jun 2001 | 25 Years 0 Months | Current |
|
Brijesh Kumar Singh
Also directs:
Titan Biotech Limited
|
Director | 01 Oct 2023 | 2 Years 9 Months | Current |
|
Dhairya Madan
Also directs:
Titan Biotech Limited
|
Director | 01 Oct 2023 | 2 Years 9 Months | Current |
| Raja Singla | Whole-Time Director | 01 Oct 2022 | 3 Years 9 Months | Current |
Financials of Titan Biotech Limited FY 2026 filings available
Titan Biotech Limited reported revenue of ₹206.19 Cr (up 31.79% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹206.19 Cr | ₹156.45 Cr | ₹164.07 Cr | ₹144 Cr | ₹152.81 Cr | ₹142.24 Cr | ₹79.44 Cr | ₹64.91 Cr |
| Other Income | ₹5.41 Cr | ₹3.91 Cr | ₹1.75 Cr | ₹1.94 Cr | ₹1.02 Cr | ₹78.84 Lakh | ₹44.95 Lakh | ₹68.65 Lakh |
| Total Income | ₹211.6 Cr | ₹160.36 Cr | ₹165.82 Cr | ₹145.94 Cr | ₹153.83 Cr | ₹143.03 Cr | ₹79.89 Cr | ₹65.59 Cr |
| Cost of Materials Consumed | ₹99.16 Cr | ₹75.48 Cr | ₹80.89 Cr | ₹70.81 Cr | ₹75.48 Cr | ₹67.3 Cr | ₹40.24 Cr | ₹36.55 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹2.97 Cr | -₹2.85 Cr | -₹5.29 Cr | -₹93.21 Lakh | -₹60.16 Lakh | -₹2.73 Cr | -₹89.24 Lakh | -₹3.85 Cr |
| Employee Benefit Expense | ₹32.36 Cr | ₹26.38 Cr | ₹23.71 Cr | ₹18.21 Cr | ₹16.14 Cr | ₹14.05 Cr | ₹12.47 Cr | ₹10.27 Cr |
| Finance Costs | ₹91.39 Lakh | ₹80.18 Lakh | ₹1.17 Cr | ₹74.59 Lakh | ₹1.28 Cr | ₹1.67 Cr | ₹2.34 Cr | ₹2.29 Cr |
| Depreciation & Amortisation | ₹4.93 Cr | ₹4.17 Cr | ₹3.33 Cr | ₹2.6 Cr | ₹2.54 Cr | ₹2.22 Cr | ₹1.8 Cr | ₹1.71 Cr |
| Other Expenses | ₹39.03 Cr | ₹32.02 Cr | ₹30.47 Cr | ₹26.4 Cr | ₹20.8 Cr | ₹17.49 Cr | ₹14.14 Cr | ₹13.08 Cr |
| Total Expenses | ₹173.43 Cr | ₹136 Cr | ₹134.29 Cr | ₹117.83 Cr | ₹115.63 Cr | ₹100 Cr | ₹70.1 Cr | ₹60.05 Cr |
| Profit Before Exceptional Items & Tax | ₹38.17 Cr | ₹24.37 Cr | ₹31.53 Cr | ₹28.12 Cr | ₹38.2 Cr | ₹43.03 Cr | ₹9.79 Cr | ₹5.54 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹32.44 Lakh | ₹61.41 Lakh | ₹0 |
| Profit Before Tax | ₹38.17 Cr | ₹24.37 Cr | ₹31.53 Cr | ₹28.12 Cr | ₹38.2 Cr | ₹42.71 Cr | ₹10.4 Cr | ₹5.54 Cr |
| Total Tax Expense | ₹10.73 Cr | ₹6.1 Cr | ₹7.87 Cr | ₹7.09 Cr | ₹9.65 Cr | ₹11 Cr | ₹2.57 Cr | ₹1.63 Cr |
| Net Profit | ₹29.89 Cr | ₹21.53 Cr | ₹24.85 Cr | ₹24.84 Cr | ₹28.74 Cr | ₹31.71 Cr | ₹7.84 Cr | ₹3.91 Cr |
| attributable to Owners | - | - | - | - | - | - | ₹7.07 Cr | - |
| attributable to NCI | - | - | - | - | - | - | ₹77.16 Lakh | - |
| Other Comprehensive Income | -₹8.82 Lakh | ₹7.3 Lakh | ₹17.48 Lakh | ₹0 | ₹0 | ₹5.21 Lakh | -₹5.02 Lakh | ₹9.78 Lakh |
| Total Comprehensive Income | ₹29.8 Cr | ₹21.6 Cr | ₹25.03 Cr | ₹24.84 Cr | ₹28.74 Cr | ₹31.76 Cr | ₹7.79 Cr | ₹4.01 Cr |
| EBITDA (computed) | ₹44.01 Cr | ₹29.34 Cr | ₹36.03 Cr | ₹31.46 Cr | ₹42.02 Cr | ₹46.91 Cr | ₹13.93 Cr | ₹9.55 Cr |
| Basic EPS | ₹7.23 | ₹26.06 | ₹28.64 | ₹30.06 | ₹30.66 | ₹36.71 | ₹8.55 | ₹0.80 |
| Diluted EPS | ₹7.23 | ₹26.06 | ₹28.64 | ₹30.06 | ₹30.66 | ₹36.71 | ₹8.55 | ₹0.80 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹213.88 Cr | ₹174.71 Cr | ₹156.58 Cr | ₹134.52 Cr | ₹143.4 Cr | ₹100.72 Cr | ₹76.04 Cr | ₹64.73 Cr |
| Non-current Assets | ₹128.64 Cr | ₹95.67 Cr | ₹84.41 Cr | ₹66.21 Cr | ₹52.05 Cr | ₹41.39 Cr | ₹31.84 Cr | ₹29.59 Cr |
| Current Assets | ₹85.24 Cr | ₹79.04 Cr | ₹72.17 Cr | ₹68.31 Cr | ₹91.35 Cr | ₹59.33 Cr | ₹44.2 Cr | ₹35.14 Cr |
| Property, Plant & Equipment | ₹51.34 Cr | ₹57.16 Cr | ₹51.94 Cr | ₹35.81 Cr | ₹42.05 Cr | ₹33.52 Cr | ₹31.06 Cr | ₹28.92 Cr |
| Inventories | ₹55.77 Cr | ₹50.72 Cr | ₹45.57 Cr | ₹36.17 Cr | ₹42.29 Cr | ₹32.54 Cr | ₹27.98 Cr | ₹21.13 Cr |
| Trade Receivables | ₹22.83 Cr | ₹18.82 Cr | ₹18.66 Cr | ₹21.01 Cr | ₹21.67 Cr | ₹18.1 Cr | ₹11.86 Cr | ₹9.24 Cr |
| Cash & Equivalents | ₹1.48 Cr | ₹5.13 Cr | ₹2.84 Cr | ₹4.86 Cr | ₹15.61 Cr | ₹5.45 Cr | ₹1.83 Cr | ₹1.87 Cr |
| Equity (Net Worth) | ₹181.55 Cr | ₹153.4 Cr | ₹133.45 Cr | ₹109.91 Cr | ₹105.41 Cr | ₹72.48 Cr | ₹41.55 Cr | ₹33.76 Cr |
| Equity Share Capital | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr |
| Borrowings (Non-current) | ₹32.67 Lakh | ₹18.43 Lakh | ₹45.33 Lakh | ₹29.9 Lakh | ₹8.4 Cr | ₹4.86 Cr | ₹11.55 Cr | ₹13.17 Cr |
| Borrowings (Current) | ₹3.34 Cr | ₹1.92 Cr | ₹6.72 Cr | ₹6.7 Cr | ₹7.47 Cr | ₹8.29 Cr | ₹11.34 Cr | ₹9.68 Cr |
| Total Debt (computed) | ₹3.67 Cr | ₹2.1 Cr | ₹7.17 Cr | ₹7 Cr | ₹15.87 Cr | ₹13.14 Cr | ₹22.89 Cr | ₹22.84 Cr |
| Current Liabilities | ₹25.96 Cr | ₹17.74 Cr | ₹19.13 Cr | ₹20.35 Cr | ₹25.23 Cr | ₹19.11 Cr | ₹20.43 Cr | ₹15.78 Cr |
| Total Liabilities | ₹32.34 Cr | ₹21.3 Cr | ₹23.13 Cr | ₹24.6 Cr | ₹37.99 Cr | ₹28.24 Cr | ₹34.49 Cr | ₹30.97 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹30.42 Cr | ₹20.12 Cr | ₹21.15 Cr | ₹21.18 Cr | ₹22.86 Cr |
| Investing Cash Flow | -₹34.41 Cr | -₹9.87 Cr | -₹20.3 Cr | -₹20.73 Cr | -₹18.79 Cr |
| Financing Cash Flow | ₹34.39 Lakh | -₹7.96 Cr | -₹2.87 Cr | -₹2.4 Cr | ₹6.08 Cr |
| Capital Expenditure | ₹9.31 Cr | ₹9.39 Cr | ₹8.71 Cr | ₹13.17 Cr | ₹18.79 Cr |
| Free Cash Flow (computed) | ₹21.11 Cr | ₹10.73 Cr | ₹12.44 Cr | ₹8.01 Cr | ₹4.07 Cr |
| Dividends Paid | ₹1.65 Cr | ₹1.65 Cr | ₹1.49 Cr | ₹1.24 Cr | ₹1.24 Cr |
| Net Change in Cash | -₹3.65 Cr | ₹2.29 Cr | -₹2.02 Cr | -₹1.95 Cr | ₹10.16 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹48.83 Cr | ₹56.51 Cr | ₹54.35 Cr | ₹46.5 Cr | ₹35.17 Cr | ₹38.28 Cr | ₹39.89 Cr | ₹43.11 Cr |
| Other Income | ₹2.11 Cr | ₹1.26 Cr | ₹1.32 Cr | ₹72.22 Lakh | ₹1.38 Cr | ₹1.59 Cr | ₹31.86 Lakh | ₹62.37 Lakh |
| Total Income | ₹50.94 Cr | ₹57.76 Cr | ₹55.68 Cr | ₹47.22 Cr | ₹36.55 Cr | ₹39.87 Cr | ₹40.21 Cr | ₹43.74 Cr |
| Cost of Materials Consumed | ₹25.91 Cr | ₹27.28 Cr | ₹27.43 Cr | ₹18.55 Cr | ₹17.3 Cr | ₹19.64 Cr | ₹16.19 Cr | ₹22.35 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹7.08 Cr | ₹9.12 Lakh | -₹1.38 Cr | ₹5.4 Cr | -₹2.29 Cr | -₹1.3 Cr | ₹1.32 Cr | -₹57.87 Lakh |
| Employee Benefit Expense | ₹9.44 Cr | ₹8.53 Cr | ₹7.38 Cr | ₹7.01 Cr | ₹6.94 Cr | ₹6.67 Cr | ₹6.5 Cr | ₹6.27 Cr |
| Finance Costs | ₹23.72 Lakh | ₹25.74 Lakh | ₹22.41 Lakh | ₹19.52 Lakh | ₹7.88 Lakh | ₹14.85 Lakh | ₹26.55 Lakh | ₹30.9 Lakh |
| Depreciation & Amortisation | ₹1.3 Cr | ₹1.27 Cr | ₹1.21 Cr | ₹1.15 Cr | ₹84.33 Lakh | ₹1.18 Cr | ₹1.1 Cr | ₹1.05 Cr |
| Other Expenses | ₹10.86 Cr | ₹9.78 Cr | ₹11.6 Cr | ₹6.8 Cr | ₹8.64 Cr | ₹8.43 Cr | ₹8.12 Cr | ₹6.83 Cr |
| Total Expenses | ₹40.66 Cr | ₹47.2 Cr | ₹46.46 Cr | ₹39.11 Cr | ₹31.52 Cr | ₹34.76 Cr | ₹33.49 Cr | ₹36.22 Cr |
| Profit Before Exceptional Items & Tax | ₹10.28 Cr | ₹10.56 Cr | ₹9.22 Cr | ₹8.11 Cr | ₹5.03 Cr | ₹5.1 Cr | ₹6.72 Cr | ₹7.52 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10.28 Cr | ₹10.56 Cr | ₹9.22 Cr | ₹8.11 Cr | ₹5.03 Cr | ₹5.1 Cr | ₹6.72 Cr | ₹7.52 Cr |
| Total Tax Expense | ₹3.73 Cr | ₹2.69 Cr | ₹2.36 Cr | ₹1.95 Cr | ₹1.26 Cr | ₹1.3 Cr | ₹1.71 Cr | ₹1.82 Cr |
| Net Profit | ₹6.73 Cr | ₹8.53 Cr | ₹7.76 Cr | ₹6.86 Cr | ₹4.05 Cr | ₹4.39 Cr | ₹6.7 Cr | ₹6.4 Cr |
| attributable to Owners | - | - | ₹0 | ₹0 | - | - | - | - |
| attributable to NCI | - | - | ₹0 | ₹0 | - | - | - | - |
| Other Comprehensive Income | -₹14.3 Lakh | ₹1.83 Lakh | ₹1.82 Lakh | ₹1.83 Lakh | -₹5.81 Lakh | ₹4.37 Lakh | ₹4.37 Lakh | ₹4.37 Lakh |
| Total Comprehensive Income | ₹6.59 Cr | ₹8.55 Cr | ₹7.78 Cr | ₹6.88 Cr | ₹3.99 Cr | ₹4.43 Cr | ₹6.74 Cr | ₹6.44 Cr |
| EBITDA (computed) | ₹11.82 Cr | ₹12.09 Cr | ₹10.65 Cr | ₹9.46 Cr | ₹5.95 Cr | ₹6.44 Cr | ₹8.08 Cr | ₹8.87 Cr |
| Basic EPS | ₹1.63 | ₹10.32 | ₹9.40 | ₹8.30 | ₹4.90 | ₹5.31 | ₹8.10 | ₹7.74 |
| Diluted EPS | ₹1.63 | ₹10.32 | ₹9.40 | ₹8.30 | ₹4.90 | ₹5.31 | ₹8.10 | ₹7.74 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹206.19 Cr | ₹156.45 Cr | ₹164.07 Cr | ₹144 Cr | ₹123.55 Cr | ₹122.46 Cr | ₹69.48 Cr | ₹58.24 Cr |
| Other Income | ₹5.41 Cr | ₹3.91 Cr | ₹1.75 Cr | ₹1.94 Cr | ₹94.13 Lakh | ₹65.99 Lakh | ₹40.95 Lakh | ₹65.14 Lakh |
| Total Income | ₹211.6 Cr | ₹160.36 Cr | ₹165.82 Cr | ₹145.94 Cr | ₹124.49 Cr | ₹123.12 Cr | ₹69.89 Cr | ₹58.89 Cr |
| Cost of Materials Consumed | ₹99.16 Cr | ₹75.48 Cr | ₹80.89 Cr | ₹70.81 Cr | ₹59.12 Cr | ₹55.54 Cr | ₹36.74 Cr | ₹34.5 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹2.97 Cr | -₹2.85 Cr | -₹5.29 Cr | -₹93.21 Lakh | -₹17.3 Lakh | -₹2.23 Cr | -₹65.44 Lakh | -₹3.88 Cr |
| Employee Benefit Expense | ₹32.36 Cr | ₹26.38 Cr | ₹23.71 Cr | ₹18.21 Cr | ₹14.33 Cr | ₹12.04 Cr | ₹10.03 Cr | ₹8.49 Cr |
| Finance Costs | ₹91.39 Lakh | ₹80.18 Lakh | ₹1.17 Cr | ₹74.59 Lakh | ₹78.39 Lakh | ₹1.28 Cr | ₹1.9 Cr | ₹2.04 Cr |
| Depreciation & Amortisation | ₹4.93 Cr | ₹4.17 Cr | ₹3.33 Cr | ₹2.6 Cr | ₹2.37 Cr | ₹2.1 Cr | ₹1.75 Cr | ₹1.68 Cr |
| Other Expenses | ₹39.03 Cr | ₹32.02 Cr | ₹30.47 Cr | ₹26.4 Cr | ₹19.09 Cr | ₹15.3 Cr | ₹12.5 Cr | ₹11.72 Cr |
| Total Expenses | ₹173.43 Cr | ₹136 Cr | ₹134.29 Cr | ₹117.83 Cr | ₹95.52 Cr | ₹84.03 Cr | ₹62.26 Cr | ₹54.54 Cr |
| Profit Before Exceptional Items & Tax | ₹38.17 Cr | ₹24.37 Cr | ₹31.53 Cr | ₹28.12 Cr | ₹28.97 Cr | ₹39.09 Cr | ₹7.63 Cr | ₹4.36 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹32.44 Lakh | ₹61.41 Lakh | ₹0 |
| Profit Before Tax | ₹38.17 Cr | ₹24.37 Cr | ₹31.53 Cr | ₹28.12 Cr | ₹28.97 Cr | ₹38.76 Cr | ₹8.24 Cr | ₹4.36 Cr |
| Total Tax Expense | ₹10.73 Cr | ₹6.1 Cr | ₹7.87 Cr | ₹7.09 Cr | ₹7.28 Cr | ₹9.99 Cr | ₹2.04 Cr | ₹1.28 Cr |
| Net Profit | ₹27.45 Cr | ₹18.27 Cr | ₹23.66 Cr | ₹21.02 Cr | ₹21.68 Cr | ₹28.77 Cr | ₹6.2 Cr | ₹3.08 Cr |
| Other Comprehensive Income | -₹8.65 Lakh | ₹7.3 Lakh | ₹17.48 Lakh | ₹0 | -₹2.08 Lakh | ₹6.04 Lakh | -₹4.71 Lakh | ₹9.61 Lakh |
| Total Comprehensive Income | ₹27.36 Cr | ₹18.34 Cr | ₹23.84 Cr | ₹21.02 Cr | ₹21.66 Cr | ₹28.83 Cr | ₹6.15 Cr | ₹3.18 Cr |
| EBITDA (computed) | ₹44.01 Cr | ₹29.34 Cr | ₹36.03 Cr | ₹31.46 Cr | ₹32.12 Cr | ₹42.47 Cr | ₹11.27 Cr | ₹8.07 Cr |
| Basic EPS | ₹6.64 | ₹22.11 | ₹28.64 | ₹25.44 | ₹26.24 | ₹34.82 | ₹7.51 | ₹3.73 |
| Diluted EPS | ₹6.64 | ₹22.11 | ₹28.64 | ₹25.44 | ₹26.24 | ₹34.82 | ₹7.51 | ₹3.73 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹203.18 Cr | ₹174.71 Cr | ₹151.57 Cr | ₹130.7 Cr | ₹107.56 Cr | ₹86.17 Cr | ₹65.2 Cr | ₹59.82 Cr |
| Non-current Assets | ₹117.94 Cr | ₹95.67 Cr | ₹79.4 Cr | ₹62.39 Cr | ₹44.34 Cr | ₹36.03 Cr | ₹27.09 Cr | ₹27.74 Cr |
| Current Assets | ₹85.24 Cr | ₹79.04 Cr | ₹72.17 Cr | ₹68.31 Cr | ₹63.23 Cr | ₹50.14 Cr | ₹38.11 Cr | ₹32.07 Cr |
| Property, Plant & Equipment | ₹51.34 Cr | ₹57.16 Cr | ₹51.94 Cr | ₹35.81 Cr | ₹34.88 Cr | ₹26.95 Cr | ₹25.14 Cr | ₹25.81 Cr |
| Inventories | ₹55.77 Cr | ₹50.72 Cr | ₹45.57 Cr | ₹36.17 Cr | ₹34.68 Cr | ₹26.83 Cr | ₹24.14 Cr | ₹19.96 Cr |
| Trade Receivables | ₹22.83 Cr | ₹18.82 Cr | ₹18.66 Cr | ₹21.01 Cr | ₹16.36 Cr | ₹16.12 Cr | ₹10.54 Cr | ₹7.84 Cr |
| Cash & Equivalents | ₹1.48 Cr | ₹5.13 Cr | ₹2.84 Cr | ₹4.86 Cr | ₹6.81 Cr | ₹5.31 Cr | ₹1.7 Cr | ₹1.59 Cr |
| Equity (Net Worth) | ₹170.84 Cr | ₹153.4 Cr | ₹128.44 Cr | ₹106.09 Cr | ₹86.24 Cr | ₹65.82 Cr | ₹37.81 Cr | ₹31.66 Cr |
| Equity Share Capital | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr | ₹8.26 Cr |
| Borrowings (Non-current) | ₹32.67 Lakh | ₹18.43 Lakh | ₹45.33 Lakh | ₹29.9 Lakh | ₹1.08 Cr | ₹1.83 Cr | ₹8.48 Cr | ₹12.02 Cr |
| Borrowings (Current) | ₹3.34 Cr | ₹1.92 Cr | ₹6.72 Cr | ₹6.7 Cr | ₹4.72 Cr | ₹5.71 Cr | ₹8.41 Cr | ₹8.84 Cr |
| Total Debt (computed) | ₹3.67 Cr | ₹2.1 Cr | ₹7.17 Cr | ₹7 Cr | ₹5.8 Cr | ₹7.54 Cr | ₹16.89 Cr | ₹20.85 Cr |
| Current Liabilities | ₹25.96 Cr | ₹17.74 Cr | ₹19.13 Cr | ₹20.35 Cr | ₹16.42 Cr | ₹14.37 Cr | ₹16.47 Cr | ₹14.16 Cr |
| Total Liabilities | ₹32.34 Cr | ₹21.3 Cr | ₹23.13 Cr | ₹24.6 Cr | ₹21.32 Cr | ₹20.35 Cr | ₹27.39 Cr | ₹28.16 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹30.42 Cr | ₹20.12 Cr | ₹21.15 Cr | ₹21.18 Cr | ₹21.95 Cr |
| Investing Cash Flow | -₹34.41 Cr | -₹9.87 Cr | -₹20.3 Cr | -₹20.73 Cr | -₹16.44 Cr |
| Financing Cash Flow | ₹34.39 Lakh | -₹7.96 Cr | -₹2.87 Cr | -₹2.4 Cr | -₹4.01 Cr |
| Capital Expenditure | ₹9.31 Cr | ₹9.39 Cr | ₹8.71 Cr | ₹13.17 Cr | ₹13.68 Cr |
| Free Cash Flow (computed) | ₹21.11 Cr | ₹10.73 Cr | ₹12.44 Cr | ₹8.01 Cr | ₹8.27 Cr |
| Dividends Paid | ₹1.65 Cr | ₹1.65 Cr | ₹1.49 Cr | ₹1.24 Cr | ₹1.24 Cr |
| Net Change in Cash | -₹3.65 Cr | ₹2.29 Cr | -₹2.02 Cr | -₹1.95 Cr | ₹1.51 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹48.83 Cr | ₹56.51 Cr | ₹54.35 Cr | ₹46.5 Cr | ₹35.17 Cr | ₹38.28 Cr | ₹39.89 Cr | ₹43.11 Cr |
| Other Income | ₹2.11 Cr | ₹1.26 Cr | ₹1.32 Cr | ₹72.22 Lakh | ₹1.38 Cr | ₹1.59 Cr | ₹31.86 Lakh | ₹62.37 Lakh |
| Total Income | ₹50.94 Cr | ₹57.76 Cr | ₹55.68 Cr | ₹47.22 Cr | ₹36.55 Cr | ₹39.87 Cr | ₹40.21 Cr | ₹43.74 Cr |
| Cost of Materials Consumed | ₹25.91 Cr | ₹27.28 Cr | ₹27.43 Cr | ₹18.55 Cr | ₹17.3 Cr | ₹19.64 Cr | ₹16.19 Cr | ₹22.35 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹7.08 Cr | ₹9.12 Lakh | -₹1.38 Cr | ₹5.4 Cr | -₹2.29 Cr | -₹1.3 Cr | ₹1.32 Cr | -₹57.87 Lakh |
| Employee Benefit Expense | ₹9.44 Cr | ₹8.53 Cr | ₹7.38 Cr | ₹7.01 Cr | ₹6.94 Cr | ₹6.67 Cr | ₹6.5 Cr | ₹6.27 Cr |
| Finance Costs | ₹23.72 Lakh | ₹25.74 Lakh | ₹22.41 Lakh | ₹19.52 Lakh | ₹7.88 Lakh | ₹14.85 Lakh | ₹26.55 Lakh | ₹30.9 Lakh |
| Depreciation & Amortisation | ₹1.3 Cr | ₹1.27 Cr | ₹1.21 Cr | ₹1.15 Cr | ₹84.33 Lakh | ₹1.18 Cr | ₹1.1 Cr | ₹1.05 Cr |
| Other Expenses | ₹10.86 Cr | ₹9.78 Cr | ₹11.6 Cr | ₹6.8 Cr | ₹8.64 Cr | ₹8.43 Cr | ₹8.12 Cr | ₹6.83 Cr |
| Total Expenses | ₹40.66 Cr | ₹47.2 Cr | ₹46.46 Cr | ₹39.11 Cr | ₹31.52 Cr | ₹34.76 Cr | ₹33.49 Cr | ₹36.22 Cr |
| Profit Before Exceptional Items & Tax | ₹10.28 Cr | ₹10.56 Cr | ₹9.22 Cr | ₹8.11 Cr | ₹5.03 Cr | ₹5.1 Cr | ₹6.72 Cr | ₹7.52 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10.28 Cr | ₹10.56 Cr | ₹9.22 Cr | ₹8.11 Cr | ₹5.03 Cr | ₹5.1 Cr | ₹6.72 Cr | ₹7.52 Cr |
| Total Tax Expense | ₹3.73 Cr | ₹2.69 Cr | ₹2.36 Cr | ₹1.95 Cr | ₹1.26 Cr | ₹1.3 Cr | ₹1.71 Cr | ₹1.82 Cr |
| Net Profit | ₹6.56 Cr | ₹7.87 Cr | ₹6.86 Cr | ₹6.16 Cr | ₹3.77 Cr | ₹3.8 Cr | ₹5 Cr | ₹5.7 Cr |
| Other Comprehensive Income | -₹14.13 Lakh | ₹1.83 Lakh | ₹1.82 Lakh | ₹1.83 Lakh | -₹5.81 Lakh | ₹4.37 Lakh | ₹4.37 Lakh | ₹4.37 Lakh |
| Total Comprehensive Income | ₹6.41 Cr | ₹7.89 Cr | ₹6.88 Cr | ₹6.18 Cr | ₹3.71 Cr | ₹3.85 Cr | ₹5.05 Cr | ₹5.74 Cr |
| EBITDA (computed) | ₹11.82 Cr | ₹12.09 Cr | ₹10.65 Cr | ₹9.46 Cr | ₹5.95 Cr | ₹6.44 Cr | ₹8.08 Cr | ₹8.87 Cr |
| Basic EPS | ₹1.59 | ₹9.52 | ₹8.30 | ₹7.46 | ₹4.56 | ₹4.60 | ₹6.05 | ₹6.90 |
| Diluted EPS | ₹1.59 | ₹9.52 | ₹8.30 | ₹7.46 | ₹4.56 | ₹4.60 | ₹6.05 | ₹6.90 |
Shareholding Pattern of Titan Biotech Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 55.78%, domestic institutional investors hold 0.03%, retail and other public shareholders hold 44.19% of Titan Biotech Limited. The company had 17,457 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 55.78% | 55.78% | 55.78% | 55.88% | 55.88% | 55.88% |
| Public | 44.22% | 44.22% | 44.22% | 44.12% | 44.12% | 44.12% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 55.78% | 55.88% | 55.88% |
| Public | 44.22% | 44.12% | 44.12% |
| Promoter change (YoY, %pts) | -0.10 | +0.00 | - |
Group Structure of Titan Biotech Limited
Titan Biotech Limited has 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Titan Biotech Limited's business expansion strategy and organizational complexity.
Charges & Borrowings of Titan Biotech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2025 | Hdfc Bank Limited | ₹45 Lakh | Open |
| 30 Dec 2024 | Others | ₹17 Cr | Open |
| 13 Dec 2024 | Hdfc Bank Limited | ₹3.02 Cr | Open |
| 12 Aug 2024 | Hdfc Bank Limited | ₹12 Lakh | Open |
| 21 Jul 2022 | Hdfc Bank Limited | ₹45 Lakh | Open |
Total charge records: 10 View all charges
Employees and EPFO Compliance at Titan Biotech Limited
Titan Biotech Limited has a workforce of 377 employees as of Mar 28, 2024.
Employee Count & EPFO Data of Titan Biotech Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Titan Biotech Limited
GSTIN & GST Filing Data of Titan Biotech Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Titan Biotech Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Titan Biotech Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Titan Biotech Limited
MSME Payment Delays by Titan Biotech Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Titan Biotech Limited
Subsidiaries & Group Companies of Titan Biotech Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Titan Biotech Limited with ownership details.
MCA Filings & Documents of Titan Biotech Limited
MCA Filings & Documents of Titan Biotech Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Titan Biotech Limited
Recent News on Titan Biotech Limited
Frequently Asked Questions about Titan Biotech Limited
Titan Biotech Limited is an active public limited company in the life sciences sector based in Bhiwadi, Rajasthan, India. It was incorporated on 18 February 1992 (34+ years old) and is registered under CIN L74999RJ1992PLC013387. Listed on BSE: 524717. The company has 377 employees.
Titan Biotech Limited reported revenue of ₹160.36 Cr for FY 2025 (down 3.00% YoY).
The current directors of Titan Biotech Limited are:
The primary industry of Titan Biotech Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Yes. Titan Biotech Limited is listed on BSE with code 524717.
Titan Biotech Limited can be reached at the registered office: A – 902 A Riico.Indl.Area Phase – Iii, Bhiwadi, Rajasthan, India – 301019, or through the website titanbiotechltd.com.